Troponin I and T as cardiac-specific biomarkers are highly useful tools not only in the diagnosis of acute coronary syndromes but also as independent predictors of several other clinical conditions. High-sensitivity cardiac troponin (hs-cTn) assays allow the detection of considerably low concentrations of cardiac troponin in apparently healthy and asymptomatic individuals, being a candidate tool for cardiovascular risk stratification in the general population. A group of Greek experts summarized the bulk of evidence regarding the use of hs-cTnI as a predictor of cardiovascular events and mortality in apparently healthy individuals and its additive value on top of existing risk stratification methods. This document could serve as a guide for the incorporation of hs-cTnI as an additional risk stratification tool in cardiovascular prevention strategies in apparently healthy individuals.

肌钙蛋白 I 和 T 作为心脏特异性生物标志物，不仅在诊断急性冠状动脉综合征方面是非常有用的工具，而且还可以作为其他几种临床病症的独立预测因子。高灵敏度心肌肌钙蛋白 (hs-cTn) 检测可以检测表面健康和无症状个体中相当低浓度的心肌肌钙蛋白，是一般人群心血管风险分层的候选工具。一组希腊专家总结了有关使用 hs-cTnI 作为表面健康个体心血管事件和死亡率预测因子的大量证据，及其在现有风险分层方法之上的附加价值。本文件可作为将 hs-cTnI 作为附加风险分层工具纳入表面健康个体心血管预防策略的指南。